Share of the pharma major fell about 4 per cent in the first one hour of the trade on Friday. Experts see concerns over the US business, as well as, pressure on operating performance as key drags. Despite near-term headwinds, most brokerage firms maintained their rating and target prices but slashed earnings per share (EPS) estimates for FY23-24.
Centre to impose stock limits on tur and urad dal till October 31
The move has come after the price of tur and urad saw a sharp jump in prices this week. The prices of the two commodities
June 2, 2023